New evidence rekindles the hormone therapy debate
- PMID: 20406546
- PMCID: PMC3727643
- DOI: 10.1783/147118910791069277
New evidence rekindles the hormone therapy debate
Similar articles
-
Estrogen replacement therapy in women: prevention and treatment of coronary artery disease.Am J Crit Care. 1994 Sep;3(5):398-401. Am J Crit Care. 1994. PMID: 8000465 No abstract available.
-
[Hormone replacement therapy for prevention in postmenopausal women: the end of controversy?].Med Clin (Barc). 2002 Oct 5;119(11):416-7. doi: 10.1016/s0025-7753(02)73437-4. Med Clin (Barc). 2002. PMID: 12381276 Spanish. No abstract available.
-
Contradictory hormone studies renew debate over breast cancer link.Am J Health Syst Pharm. 1995 Oct 1;52(19):2066, 2076. doi: 10.1093/ajhp/52.19.2066. Am J Health Syst Pharm. 1995. PMID: 8535935 No abstract available.
-
Weighing the risks and benefits of hormone therapy.JAAPA. 2003 Jun;16(6):45-7. JAAPA. 2003. PMID: 14968505 Review. No abstract available.
-
Hormone replacement therapy for prevention of coronary heart disease: current evidence.Curr Atheroscler Rep. 2001 Sep;3(5):399-403. doi: 10.1007/s11883-001-0078-8. Curr Atheroscler Rep. 2001. PMID: 11487451 Review.
References
-
- Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of Estrogen plus Progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33. - PubMed
-
- The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative randomized controlled trial. JAMA. 2004;291:1701–12. - PubMed
-
- Prentice RL, Anderson GL. The Women’s Health Initiative: Lessons learned. Annu Rev Public Health. 2008;29:131–50. - PubMed
-
- Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA. 2002;288:366–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources